Kariv Tomer
Insider CIK 1568077 · ELOX Director · ARNI Director · LOGC Director · KROS Director, 10% owner · ETNB Director, 10% owner · VBIV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-17 | 1,121,045 | $17.75 | $19.90M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-17 | 1,226,412 | $17.75 | $21.77M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-17 | 155,262 | $17.75 | $2.76M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-17 | 2,284,612 | $17.75 | $40.55M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 10,500 | — | $0 | 10,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-06-04 | 2025-06-06 | 5,250 | — | $0 | 5,250 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2023-01-30 | 2023-01-31 | 2,859 | — | $0 | 2,859 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2022-11-29 | 2022-11-30 | 3,539 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2022-11-29 | 2022-11-30 | 1,723 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2022-11-29 | 2022-11-30 | 1,914 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2022-11-29 | 2022-11-30 | 1,723 | — | $0 | 1,121,045 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2022-11-29 | 2022-11-30 | 3,539 | — | $0 | 2,284,612 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2022-11-29 | 2022-11-30 | 1,914 | — | $0 | 1,226,412 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2022-06-15 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2021-05-19 | 2021-05-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2021-05-13 | 2021-05-17 | 592,592 | $1.35 | $800.0K | 616,592 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2021-05-13 | 2021-05-17 | 1,422,222 | $1.35 | $1.92M | 1,989,551 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2021-05-13 | 2021-05-17 | 2,630,487 | $1.35 | $3.55M | 3,679,797 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2021-05-13 | 2021-05-17 | 1,280,624 | $1.35 | $1.73M | 1,791,470 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 6,000 | $50.00 | $300.0K | 155,262 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 14,400 | $50.00 | $720.0K | 1,228,326 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 12,966 | $50.00 | $648.3K | 1,122,768 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 26,634 | $50.00 | $1.33M | 2,288,151 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2020-05-20 | 2020-05-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 88,460 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 91,538 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 663,825 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 737,226 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 1,363,542 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 79,653 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 163,612 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 169,307 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 36,858 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 82,425 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion deriv | 2020-04-13 | 2020-04-13 | 68,654 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-04-13 | 2020-04-13 | 194,203 | $16.00 | $3.11M | 2,261,517 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 68,654 | — | $0 | 68,654 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 163,612 | — | $0 | 2,067,314 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 88,460 | — | $0 | 1,015,256 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 79,653 | — | $0 | 1,108,926 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 36,858 | — | $0 | 105,512 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 91,538 | — | $0 | 1,029,273 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-04-13 | 2020-04-13 | 94,546 | $16.00 | $1.51M | 1,109,802 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-04-13 | 2020-04-13 | 105,000 | $16.00 | $1.68M | 1,213,926 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2020-04-13 | 2020-04-13 | 43,750 | $16.00 | $700.0K | 149,262 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 82,425 | — | $0 | 926,796 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 169,307 | — | $0 | 1,903,702 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 737,226 | — | $0 | 937,735 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 663,825 | — | $0 | 844,371 | SEC↗ |
| KROS Keros Therapeutics, Inc. | C Conversion | 2020-04-13 | 2020-04-13 | 1,363,542 | — | $0 | 1,734,395 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2019-12-19 | 2019-12-20 | 10,869 | — | $0 | 10,869 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 5,500,001 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 884,671 | — | $0 | 1,134,671 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2019-06-24 | 2019-06-26 | 42,261 | $9.00 | $380.3K | 510,846 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2019-06-24 | 2019-06-26 | 46,933 | $9.00 | $422.4K | 567,329 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2019-06-24 | 2019-06-26 | 24,000 | $9.00 | $216.0K | 24,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2019-06-24 | 2019-06-26 | 86,806 | $9.00 | $781.3K | 1,049,310 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2019-05-29 | 2019-05-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2019-01-31 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2018-12-17 | 2018-12-18 | 612,997 | $1.40 | $858.2K | 1,744,969 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2018-12-17 | 2018-12-18 | 298,431 | $1.40 | $417.8K | 849,520 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2018-12-17 | 2018-12-18 | 185,714 | $1.40 | $260.0K | 185,714 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2018-12-17 | 2018-12-18 | 331,429 | $1.40 | $464.0K | 943,451 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 1,288,116 | — | $0 | 692,982 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 627,105 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion deriv | 2018-10-23 | 2018-10-25 | 696,444 | — | $0 | 328,339 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion | 2018-10-23 | 2018-10-25 | 674,431 | — | $0 | 674,431 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2018-10-23 | 2018-10-25 | 100,849 | $10.00 | $1.01M | 1,787,413 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2018-10-23 | 2018-10-25 | 112,000 | $10.00 | $1.12M | 1,686,564 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2018-10-23 | 2018-10-25 | 207,151 | $10.00 | $2.07M | 1,574,564 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion | 2018-10-23 | 2018-10-25 | 328,339 | — | $0 | 1,367,413 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | C Conversion | 2018-10-23 | 2018-10-25 | 364,643 | — | $0 | 1,039,074 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2018-10-18 | 2018-10-22 | 24,102 | — | $0 | 24,102 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2018-06-15 | 2018-06-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-04-30 | 2018-05-01 | 172,626 | $9.75 | $1.68M | 962,504 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-04-30 | 2018-05-01 | 93,333 | $9.75 | $910.0K | 520,396 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-04-30 | 2018-05-01 | 84,041 | $9.75 | $819.4K | 468,585 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-22 | 2018-03-23 | 1,600 | $8.00 | $12.8K | 427,063 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-22 | 2018-03-23 | 2,959 | $8.00 | $23.7K | 789,878 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-22 | 2018-03-23 | 1,441 | $8.00 | $11.5K | 384,544 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-21 | 2018-03-23 | 1,760 | $7.55 | $13.3K | 425,463 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-21 | 2018-03-23 | 3,255 | $7.55 | $24.6K | 786,919 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-21 | 2018-03-23 | 1,585 | $7.55 | $12.0K | 383,103 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2018-01-23 | 2018-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2016-08-15 | 2016-08-17 | 51,050 | — | $0 | 51,050 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2016-08-15 | 2016-08-17 | 131,508 | — | $0 | 131,508 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2016-08-15 | 2016-08-17 | 174,584 | — | $0 | 174,584 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-08-15 | 2016-08-17 | 263,017 | — | $0 | 1,277,905 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-08-15 | 2016-08-17 | 102,100 | — | $0 | 496,068 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-08-15 | 2016-08-17 | 349,168 | — | $0 | 1,696,495 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2016-04-07 | 2016-04-15 | 88,628 | — | $0 | 88,628 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-04-11 | 707,868 | $0.35 | $247.8K | 1,347,327 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-04-11 | 533,208 | $0.35 | $186.6K | 1,014,888 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-04-11 | 206,986 | $0.35 | $72.4K | 393,968 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-01-14 | 707,868 | $0.35 | $247.8K | 1,347,327 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-01-14 | 533,208 | $0.35 | $186.6K | 1,014,888 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-01-14 | 206,986 | $0.35 | $72.4K | 393,968 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2014-01-24 | 2014-01-28 | 34,224 | — | $0 | 34,224 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-11-04 | 2013-11-06 | 68,448 | — | $0 | 68,448 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 203,682 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 203,682 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 153,426 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 153,426 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 153,426 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 59,558 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 59,558 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 59,558 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 203,682 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-10-31 | 153,426 | — | $0 | 481,680 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-10-31 | 12,274 | $2.40 | $29.5K | 328,254 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-10-31 | 163,620 | $2.40 | $392.7K | 315,980 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-10-31 | 203,682 | — | $0 | 639,459 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-10-31 | 16,294 | $2.40 | $39.1K | 435,777 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-10-31 | 217,216 | $2.40 | $521.3K | 419,483 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-10-31 | 63,516 | $2.40 | $152.4K | 122,660 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-10-31 | 4,764 | $2.40 | $11.4K | 127,424 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-10-31 | 59,558 | — | $0 | 186,982 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-05 | 9,529 | $0.30 | $2.9K | 473,156 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-05 | 24,548 | $0.30 | $7.4K | 1,218,883 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-05 | 32,589 | $0.30 | $9.8K | 1,618,140 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 16,291 | $0.30 | $4.9K | 463,627 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 41,967 | $0.30 | $12.6K | 1,194,335 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 55,714 | $0.30 | $16.7K | 1,585,551 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-10 | 9,529 | $0.30 | $2.9K | 447,336 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-10 | 32,589 | $0.30 | $9.8K | 1,529,837 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-10 | 24,548 | $0.30 | $7.4K | 1,152,368 | SEC↗ |